Zenas BioPharma files for US IPO

By Reuters

Aug 24, 2024 12:05 am

BRISTOL-MYERS Squibb-backed Zenas BioPharma has filed to go public in the United States, a regulatory filing showed on Thursday, underscoring improving investor appetite for new listings.

The US initial public offering (IPO) market is in the early innings of a recovery on hopes of potential interest-rate cuts and lower market volatility.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

China to approve more help for weak economy

US jobless claims tick up by 3,000

Boeing to repay strikers, but will cut workforce

Nissan to lay off workers, lowers forecast

Singapore's banks flag better loan growth

Amazon mulls new investment in Anthropic

HK central bank cuts interest rate after Fed move, banks follow